Nissay Asset Management Corp Japan Lowers Position in Agilent Technologies, Inc. $A

Nissay Asset Management Corp Japan lessened its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 64.8% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 37,875 shares of the medical research company’s stock after selling 69,767 shares during the quarter. Nissay Asset Management Corp Japan’s holdings in Agilent Technologies were worth $5,031,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently modified their holdings of A. SHP Wealth Management purchased a new stake in Agilent Technologies in the fourth quarter valued at approximately $26,000. Core Wealth Advisors LLC purchased a new position in Agilent Technologies in the 4th quarter worth approximately $26,000. Navalign LLC purchased a new position in Agilent Technologies in the 4th quarter worth approximately $27,000. MV Capital Management Inc. bought a new position in shares of Agilent Technologies in the 4th quarter worth $28,000. Finally, Entrust Financial LLC bought a new position in shares of Agilent Technologies in the 4th quarter worth $31,000.

Agilent Technologies News Roundup

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Agilent reported fiscal Q3 earnings of $1.62 per share, above the $1.48-$1.49 analyst consensus, while revenue of approximately $1.88 billion also exceeded expectations. EPS increased from $1.37 a year earlier, supporting the view that profitability is improving. Agilent Technologies Q3 Earnings and Revenues Top Estimates
• Positive Sentiment: Management raised its full-year guidance following the strong quarter. Commentary highlighted product momentum, a recovery in China, improving demand and expanding margins, all of which could support additional earnings growth. Agilent Technologies Lifts Outlook After Strong Quarter
• Positive Sentiment: Several major firms raised their price targets and maintained bullish ratings after the results. Targets now range from $175 to $190, with upgrades from JPMorgan, Citi, Barclays, Goldman Sachs, Bank of America, Stifel, TD Cowen, Bernstein and RBC. Analysts Raise Agilent Technologies Price Targets
• Neutral Sentiment: Despite the improved outlook, valuation remains relatively demanding: Agilent trades at roughly 30 times earnings, with a PEG ratio above 2.7. This leaves the stock sensitive to any slowdown in demand or disappointment in future guidance.

Agilent Technologies Price Performance

Shares of NYSE:A opened at $154.47 on Monday. The company has a quick ratio of 1.56, a current ratio of 2.05 and a debt-to-equity ratio of 0.50. The stock has a market cap of $43.63 billion, a PE ratio of 30.41, a PEG ratio of 2.34 and a beta of 1.25. The company’s fifty day moving average is $140.30 and its 200 day moving average is $127.04. Agilent Technologies, Inc. has a 52 week low of $108.35 and a 52 week high of $163.75.

Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Wednesday, August 26th. The medical research company reported $1.62 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.49 by $0.13. Agilent Technologies had a net margin of 19.53% and a return on equity of 24.45%. The business had revenue of $1.88 billion during the quarter, compared to analyst estimates of $1.84 billion. During the same period in the prior year, the business posted $1.37 earnings per share. The company’s revenue was up 8.1% on a year-over-year basis. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. Research analysts anticipate that Agilent Technologies, Inc. will post 6.2 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on the stock. Wolfe Research reaffirmed a “hold” rating on shares of Agilent Technologies in a report on Tuesday, June 2nd. Wells Fargo & Company reduced their target price on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a research note on Thursday, May 28th. HSBC lowered their price target on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a research report on Wednesday, June 3rd. The Goldman Sachs Group lifted their price target on Agilent Technologies from $155.00 to $175.00 and gave the stock a “buy” rating in a research note on Thursday. Finally, Sanford C. Bernstein upped their price objective on Agilent Technologies from $155.00 to $180.00 and gave the stock an “outperform” rating in a report on Thursday. One analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat, Agilent Technologies has a consensus rating of “Moderate Buy” and a consensus target price of $170.33.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.